Mike A. Clark This is Me

Education

 Web References

1. 1. Recent Publications

   www.phoenixpharm.org/publicati - [Cached]

   Published on: 9/10/2003   Last Visited: 1/3/2006

   Holtsberg, F.W., Ensor, C. M., Bomalaski, J.S. and Clark, M.A., Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on it's pharmacological properties.
   ...
   Thomas, J.B., Holtsberg, F.W., Ensor, C. M., Bomalaski, J.S. and Clark, M.A., Arginine deiminase inhibits nitric oxide production in mice: Protection from tumor necrosis factor and endotoxin mediated hypotension and lethality.
   ...
   Dillon, B.J., Holtsberg, F.W., Ensor, C.M., Bomalaski, J.S., Clark, M.A. Biochemical Characterization of the Arginine Degrading Enzymes Arginase and Arginine Deiminase and their Effect on Nitric OxideProduction.
   ...
   Ensor, C. M., Holtsberg, F.W., Bomalaski, J.S. and Clark, M.A., Arginine deiminase inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo: mechanism of action.
   ...
   Bomalaski, J.S., Holtsberg, F.W., Ensor, C. M., and Clark, M.A., Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and pre-clinical studies.
   ...
   John S. Bomalaski, James L. Ivett, Monica Vegarra, Frederick W. Holtsberg, Charles Mark Ensor and Mike A. Clark.
   ...
   Dillon, B.J., Prieto, V.G., Curley, S.A., Ensor, C.M., Holtsberg, F.W., Bomalaski, J.S., Clark, M.A. Incidence and Distribution of Argininosuccinate Synthetase Deficiency in Human Cancers.
   ...
   Bomalaski, J.S. and Clark, M.A. Serum Uric Acid-Lowering Therapies: Where Are We Heading in Management of Hyperuricemia and the Potential Role of Uricase.